Humanizing the mdx mouse model of DMD: the long and the short of it
- PMID: 29479480
- PMCID: PMC5816599
- DOI: 10.1038/s41536-018-0045-4
Humanizing the mdx mouse model of DMD: the long and the short of it
Erratum in
-
Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it.NPJ Regen Med. 2020 Dec 21;5(1):25. doi: 10.1038/s41536-020-00112-0. NPJ Regen Med. 2020. PMID: 33349636 Free PMC article. No abstract available.
Abstract
Duchenne muscular dystrophy (DMD) is a common fatal heritable myopathy, with cardiorespiratory failure occurring by the third decade of life. There is no specific treatment for DMD cardiomyopathy, in large part due to a lack of understanding of the mechanisms underlying the cardiac failure. Mdx mice, which have the same dystrophin mutation as human patients, are of limited use, as they do not develop early dilated cardiomyopathy as seen in patients. Here we summarize the usefulness of the various commonly used DMD mouse models, highlight a model with shortened telomeres like humans, and identify directions that warrant further investigation.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Monaco AP, et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature. 1986;323:646. - PubMed
-
- Hoffman EP, Kunkel LM. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 1989;2:1019–1029. - PubMed
-
- Emery AEH. The muscular dystrophies. Lancet. 2002;359:687–695. - PubMed
-
- Chyatte S, Vignos PJ, Watkins M. Early muscular dystrophy: differential patterns of weakness in Duchenne, limb-girdle and facioscapulohumeral types. Arch. Phys. Med. Rehabil. 1966;47:499–503. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
